Aspira Women's Health Inc.
AWH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | -$0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -4.1% | 5.5% | -3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 60% | 63.8% | 68.5% | 63.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -209.5% | -75.3% | -80.1% | -145.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -212.2% | -110.9% | -81.3% | -59.1% |
| EPS Diluted | -0.13 | -0.07 | -8.58 | -0.098 |
| % Growth | -85.7% | 99.2% | -8,655.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |